Alumis (ALMS) Liabilities and Shareholders Equity (2023 - 2025)

Alumis' (ALMS) quarterly Liabilities and Shareholders Equity came in at $411.9 million in Q4 2025, up 20.81% year-on-year from $341.0 million in Q4 2024, and down 15.59% on a QoQ basis from $488.0 million in Q3 2025.

Alumis (ALMS) Liabilities and Shareholders Equity (2023 - 2025) Analysis & Trends

Alumis (ALMS) has 3 years of Liabilities and Shareholders Equity data on file, last reported at $411.9 million in Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 20.81% year-over-year to $411.9 million in Q4 2025; TTM through Dec 2025 was $1.8 billion, a 73.96% increase from a year earlier, with the FY2025 full-year figure at $411.9 million, up 20.81% from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 stood at $411.9 million, down from $488.0 million in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for ALMS reached as high as $610.9 million in Q2 2025 and fell as low as $89.6 million in Q4 2023.
  • Historically, Liabilities and Shareholders Equity has averaged $360.1 million across 3 years, with a median of $376.5 million in 2024.
  • Across the five-year window, Liabilities and Shareholders Equity soared 280.52% in 2024 and advanced 18.29% in 2025, its largest moves.
  • Year by year, Liabilities and Shareholders Equity stood at $89.6 million in 2023, then surged by 280.52% to $341.0 million in 2024, then rose by 20.81% to $411.9 million in 2025.
  • Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $411.9 million in Q4 2025, $488.0 million in Q3 2025, and $610.9 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 311.58 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 78.88 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 8.55 Bn
4 NuCana 279.75 Bn 279.75 Bn - 39.68 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 26.48 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 40.87 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 811.27 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 10.03 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.25 Bn
10 Alumis 2.41 Bn 2.10 Bn - 411.94 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 411.94 Mn
Sep 30, 2025 488.01 Mn
Jun 30, 2025 610.93 Mn
Mar 31, 2025 261.30 Mn
Dec 31, 2024 340.99 Mn
Sep 30, 2024 412.56 Mn
Jun 30, 2024 265.18 Mn
Dec 31, 2023 89.61 Mn